Source:http://linkedlifedata.com/resource/pubmed/id/11420086
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2001-6-22
|
pubmed:abstractText |
Previous studies have shown that dopamine (DA) receptor subtype-specific agonists differentially affect responding for conditioned reward D1-like agonists impair, whereas D2-like agonists enhance responding. The present study compared the effects of the D2-like agonists bromocriptine and 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT). Food-deprived rats (N=159) were preexposed to a chamber with two levers, one producing a tone (3 s) and the other turning the house lights off (3 s), for five 40-min sessions. In four subsequent 65-min conditioning sessions with the levers removed, the lights-off stimulus was paired with food (80 presentations per session). During two 40-min test sessions, the lights-off (CR) and tone (NCR) levers were replaced and responses at each lever were recorded. Confirming previous results, bromocriptine (0.50-5.0 mg/kg) dose-dependently enhanced responding on the lever producing conditioned reward. In contrast, 7-OH-DPAT had a biphasic effect on responding for conditioned reward. Low doses (0.10-0.25 mg/kg) reduced CR lever responding, whereas a higher dose of 1.0 mg/kg enhanced such responding. An intermediate dose of 0.50 mg/kg neither impaired nor enhanced CR lever responding. The biphasic profile of 7-OH-DPAT may arise through differential actions at D3 vs. D2 receptors or presynaptic vs. postsynaptic DA receptors at low and high doses, respectively.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/7-hydroxy-2-N,N-dipropylaminotetrali...,
http://linkedlifedata.com/resource/pubmed/chemical/Bromocriptine,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine D2,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrahydronaphthalenes
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0091-3057
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-200
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11420086-Animals,
pubmed-meshheading:11420086-Bromocriptine,
pubmed-meshheading:11420086-Conditioning, Operant,
pubmed-meshheading:11420086-Dopamine Agonists,
pubmed-meshheading:11420086-Dose-Response Relationship, Drug,
pubmed-meshheading:11420086-Male,
pubmed-meshheading:11420086-Rats,
pubmed-meshheading:11420086-Rats, Wistar,
pubmed-meshheading:11420086-Receptors, Dopamine D2,
pubmed-meshheading:11420086-Reward,
pubmed-meshheading:11420086-Tetrahydronaphthalenes
|
pubmed:articleTitle |
Biphasic effects of 7-OH-DPAT on the acquisition of responding for conditioned reward in rats.
|
pubmed:affiliation |
Department of Psychology, Queen's University, K7L 3N6, Kingston, ON, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|